Effects of inclisiran therapy on metabolomic and lipoproteomic profiles in dyslipidemic patients

Patrussi, Jacopo et al.

Iris Unifi Prod · Other

nmr spectroscopy, pcsk9 inhibitor, dyslipidemia, lipoproteomic, metabolomics

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 398940
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.